News about Merck
Novartis and Amgen want to find out with an experimental drug.
AbbVie and Alector hope to apply immunotherapy to dementia and Alzheimer's.
This is your Cyber Saturday edition of Fortune's tech newsletter for October 7, 2017.
New research shows that some companies are developing strategies to address it.
Hackers have learned to compromise software supply chains.